RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 136 filers reported holding RELAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,233,946 | -29.2% | 384,536 | +5.7% | 0.00% | -33.3% |
| Q2 2023 | $4,570,368 | +15.7% | 363,883 | +51.4% | 0.00% | 0.0% |
| Q1 2023 | $3,950,553 | +20.5% | 240,381 | +9.6% | 0.00% | 0.0% |
| Q4 2022 | $3,277,312 | -33.1% | 219,365 | +0.2% | 0.00% | -25.0% |
| Q3 2022 | $4,900,000 | +32.3% | 219,035 | -0.9% | 0.00% | +33.3% |
| Q2 2022 | $3,703,000 | -39.6% | 221,084 | +7.9% | 0.00% | -25.0% |
| Q1 2022 | $6,132,000 | -2.5% | 204,883 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,290,000 | +0.7% | 204,822 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $6,245,000 | -13.8% | 198,067 | +0.0% | 0.00% | -20.0% |
| Q2 2021 | $7,245,000 | +83.2% | 198,004 | +73.1% | 0.01% | +66.7% |
| Q1 2021 | $3,954,000 | -18.2% | 114,385 | -1.6% | 0.00% | -25.0% |
| Q4 2020 | $4,832,000 | -8.2% | 116,275 | -5.9% | 0.00% | -20.0% |
| Q3 2020 | $5,262,000 | – | 123,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |